川久保 博文

Medicine & Life Sciences

1. Esophageal Neoplasms 100%
2. Esophagectomy 89%
3. Esophageal Squamous Cell Carcinoma 65%
4. Stomach Neoplasms 43%
5. Lymph Nodes 24%
6. Neoplasm Metastasis 21%
7. Neoplasms 20%
8. Gastrectomy 20%
9. Survival 17%
10. Chemoradiotherapy 16%
11. Recurrence 16%
12. Stomach 16%
13. Lymph Node Excision 16%
14. Japan 15%
15. Postoperative Complications 12%
16. Cisplatin 12%
17. Carcinoma 11%
18. Drug Therapy 11%
19. Pneumonia 10%
20. Endoscopic Mucosal Resection 9%
21. Cohort Studies 9%
22. Anastomotic Leak 9%
23. Neoadjuvant Therapy 8%
24. Esophagus 8%
25. Fluorouracil 8%
26. Alcoholics 8%
27. Retrospective Studies 8%
28. Therapeutics 7%
29. Fibrinogen 7%
30. Thorax 7%
31. Squamous Cell Carcinoma 6%
32. Surgical Wound Infection 6%
33. olanexidine 6%
34. Sarcopenia 6%
35. Enteral Nutrition 6%
36. Dissection 6%
37. Thoracic Duct 6%
38. Esophagogastric Junction 6%
39. Prospective Studies 5%
40. Artificial Intelligence 5%
41. Safety 5%
42. Endoscopy 5%
43. CCR7 Receptors 5%